Pharmaceutical solid state development

Polymorphism screening, salt and co-crystal selection

Crysforma provides complete scientific support for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of active pharmaceutical ingredients or intermediates.

Crysforma has developed its own crystallization screening methodology based on the combination of several crystallization procedures. We use high-throughput crystallization systems controlled by highly skilled scientists to maximize the information drawn from each experiment.

Our projects are always carried out in close collaboration with the client, adapted to the customer's needs and under strict confidentiality conditions. Crysforma is a technology development unit belonging to the Institute of Chemical research of Catalonia (ICIQ).